Reported rates: Retatrutide: 9 mg: 8.8% 12 mg: 20.9% Placebo: 0.7% [9] For comparison: Tirzepatide: 0.4% in two major studies [12] This significant jump raises a clear red flag , even though most symptoms were reported as mild and rarely led to discontinuation [9]
Before reconstituting, inspect the vial: - The powder should appear uniform and loosely packed - There should be no visible discoloration - The vial should be sealed and under vacuum or inert gas If the powder appears clumped or the vial seal is compromised, contact your supplier before proceeding
Its about improving your overall health, building confidence, and enhancing your quality of life
Semaglutide and kidney function: direct kidney protection or an artifact
The brain is most affected by acetaldehyde poisoning
Novo Nordisk filed for FDA approval of CagriSema in early 2026, with a review decision expected later this year